Protocol summary

Study aim
Comparison of Clonazepam and Lorazepam in the Treatment of methamphetamine-Poisoned Children
Design
single blind, parallel group randomized-controlled clinical trial with 30 cases are divided into 2 groups of oral Clonazepam or Lorazepam according to the random numbers each of them include 15 case. ________________________________________
Settings and conduct
In this double blind, randomized-controlled clinical trial, which is done to investigate the effect of oral benzodiazepin (Clonazepam or Lorazepam), in children under 12 year-old with methamphetamine poisoning who presented to pediatrics emergency department, Loghman Hakim hospital, Iran, according to the inclusion and exclusion criteria.After filling the permission form with parents according to the random numbers software, 30 patients are divided into 2 groups of fifteen. After initial administration of 0.2-mg/Kg intravenous Diazepam, oral benzodiazepines ( 0.05 mg/kg Clonazepam or Lorazepam) were only given once to prevent return of stimulant toxicity. Oral benzodiazepines were given when the patient was calm, and could be switched to oral regimen. Vital signs and clinical symptoms are recorded Upon arrival then every 6 hours.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Children under 12-year-old age with methamphetamine poisoning exclusion criteria: Multiple-drug poisoning
Intervention groups
After initial administration of 0.2-mg/Kg intravenous Diazepam, oral benzodiazepines ( 0.05 mg/kg Clonazepam or Lorazepam) were only given once to prevent return of stimulant toxicity. Oral benzodiazepines were given when the patient was calm, and could be switched to oral regimen.
Main outcome variables
Agitation level; duration of hospital stay; side effects of treatment (respiratory depression, deep sedation, paradoxical agitation).

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20180610040036N2
Registration date: 2020-04-18, 1399/01/30
Registration timing: retrospective

Last update: 2020-04-18, 1399/01/30
Update count: 0
Registration date
2020-04-18, 1399/01/30
Registrant information
Name
Narges Gholami
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 4442 7956
Email address
nargesgholami@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2016-03-20, 1395/01/01
Expected recruitment end date
2017-03-21, 1396/01/01
Actual recruitment start date
2017-01-01, 1395/10/12
Actual recruitment end date
2018-01-02, 1396/10/12
Trial completion date
2018-01-20, 1396/10/30
Scientific title
Comparison of Clonazepam and Lorazepam in the Treatment of Methamphetamine-Poisoned Children
Public title
" Clonazepam and Lorazepam in methamphetamine poisoning"
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Methamphetamine-Poisoned Children under 12-year-old age
Exclusion criteria:
multiple-drug poisoning
Age
From 6 months old to 144 months old
Gender
Both
Phase
4
Groups that have been masked
  • Participant
Sample size
Target sample size: 30
Actual sample size reached: 30
Randomization (investigator's opinion)
Randomized
Randomization description
First, a framework was made of numbers 1-30 , then the assignment of these numbers to group 1-2 was determined based on the random numbers table. A computer software program (www.random.org) was used to produce random numbers to allocate the medication (Clonazepam or Lorazapam) to 2 groups. Adequate medications for each group were be placed in a envelope marked with patient number and medication code.
Blinding (investigator's opinion)
Single blinded
Blinding description
After filling the permission form with parents, care giver divides the patients according to the random numbers and random numbers generator software into 2 groups and parents are not aware of the type of intervention. Nurse provider prescribes a medicine (0.05 mg/kg Clonazepam or Lorazepam) placed in the same drug-envelope and placed inside the envelope with the code assigned to each patient after initial administration of 0.2-mg/Kg intravenous Diazepam . Outcome assessor write the intervention and data is entered into the questionnaire based on the code of each person. Data analyser analysed final data bu SPSS software. ________________________________________
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shahid Beheshti university of medical sciences
Street address
Kodakyar st , Shahriary Sq , Chamran High way
City
Tehran
Province
Tehran
Postal code
19839-63113
Approval date
2016-08-28, 1395/06/07
Ethics committee reference number
IR.SBMU.RETECH.REC.1394.122

Health conditions studied

1

Description of health condition studied
Methamphetamine poisoning
ICD-10 code
F15.12
ICD-10 code description
Other stimulant abuse with intoxication

Primary outcomes

1

Description
Agitation level
Timepoint
Admission time, 6,12,18,24 hours
Method of measurement
questionnaire (Richmond Agitation)

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group 1: Oral Clonazepam
Category
Treatment - Drugs

2

Description
Intervention group 2: Oral Lorazepam
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Loghman Hakim hospital
Full name of responsible person
Fariba Farnaghi
Street address
Loghman hospital.Kargar st
City
Tehran
Province
Tehran
Postal code
1333625445
Phone
+98 21 5102 5182
Email
faribafarnaghi@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Afshin Zarghi
Street address
Arabi Ave, Daneshjoo Blvd, Velenjak
City
Tehran
Province
Tehran
Postal code
1985717434
Phone
+98 21 2243 9781
Email
zarghi@sbmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Hossein Hassanian-Moghaddam
Position
Associate professor of clinical toxicology
Latest degree
Subspecialist
Other areas of specialty/work
Toxicology
Street address
Loghman hospital.Kargar st
City
Tehran
Province
Tehran
Postal code
1333625445
Phone
+98 21 5102 5182
Email
hasanian2000@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Fariba Farnaghi
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Loghman Hakim hospital, Kargar st
City
Tehran
Province
Tehran
Postal code
1333625445
Phone
+98 21 5102 5182
Email
faribafarnaghi@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Narges Gholami
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
Loghman hospital.Kargar st
City
Tehran
Province
Tehran
Postal code
1333625445
Phone
+98 21 5102 5182
Email
nargesgholami724@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
En Final data has been given to Vice-Chancellor of Research Affairs of Shahid Beheshti University of Medical Sciences
When the data will become available and for how long
19.2.2018 -19.2.2021
To whom data/document is available
Pediatrics, Clinical toxicology flow ship
Under which criteria data/document could be used
All researchers are allowed to receive data details and protocols according professional ethics
From where data/document is obtainable
Contact with authors
What processes are involved for a request to access data/document
By email to author(faribafarnaghi@yahoo.com). It takes about 7 days.
Comments
Loading...